Literature DB >> 12957255

High intrinsic apoptosis, but not radiation-induced apoptosis, predicts better survival in rectal carcinoma patients.

Corrie A M Marijnen1, Iris D Nagtegaal, Adri A Mulder-Stapel, Peter I Schrier, Cornelis J H van de Velde, J Han J M van Krieken, Lucy T C Peltenburg.   

Abstract

PURPOSE: An important feature of malignant tumors is the disturbance in the balance between proliferation and cell death. We evaluated the relevance of intrinsic and radiation-induced apoptosis and proliferation for prognosis in rectal cancer patients. METHODS AND MATERIALS: Patients were selected from a study that randomized for preoperative radiotherapy (RT). Apoptosis and proliferation were scored using specific antibodies in immunohistochemistry. The number of positive cells per square millimeter of carcinoma cells was determined in 98 randomly selected tumors, of which 45 had been irradiated. For the survival analyses, a cohort of 104 patients without positive circumferential resection margins was selected.
RESULTS: In nonirradiated patients, high levels of intrinsic apoptosis correlated with better local control (p = 0.04) and better cancer-specific survival (p = 0.02). RT increased the median amount of apoptosis from 10.8 to 21.5 cells/mm(2) (p = 0.004), but this was not predictive for survival. The amount of proliferative cells was not altered after RT and had no influence on prognosis.
CONCLUSIONS: Intrinsic apoptosis correlated with both local control and cancer-specific survival, but proliferation was not predictive for prognosis. However, although RT increased apoptosis, its prognostic value was lost after RT. This is possibly because in rectal cancer, the proliferative status of tumors is always high and the aggressiveness of the tumor is determined by the number of "spontaneous" apoptotic tumor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957255     DOI: 10.1016/s0360-3016(03)00580-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

1.  DNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence.

Authors:  Anne Benard; Eliane C M Zeestraten; Inès J Goossens-Beumer; Hein Putter; Cornelis J H van de Velde; Dave S B Hoon; Peter J K Kuppen
Journal:  Apoptosis       Date:  2014-11       Impact factor: 4.677

2.  Chromatin status of apoptosis genes correlates with sensitivity to chemo-, immune- and radiation therapy in colorectal cancer cell lines.

Authors:  Anne Benard; Connie M Janssen; Peter J van den Elsen; Marja C J A van Eggermond; Dave S B Hoon; Cornelis J H van de Velde; Peter J K Kuppen
Journal:  Apoptosis       Date:  2014-12       Impact factor: 4.677

3.  Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours.

Authors:  M J E M Gosens; R C Dresen; H J T Rutten; G A P Nieuwenhuijzen; J A W M van der Laak; H Martijn; I Tan-Go; I D Nagtegaal; A J C van den Brule; J H J M van Krieken
Journal:  Ann Oncol       Date:  2008-07-29       Impact factor: 32.976

4.  Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study.

Authors:  Annelies Debucquoy; Laurence Goethals; Louis Libbrecht; Christiaan Perneel; Karel Geboes; Nadine Ectors; William H McBride; Karin Haustermans
Journal:  Int J Colorectal Dis       Date:  2008-12-03       Impact factor: 2.571

5.  Morphological features and molecular markers in rectal cancer from 95 patients included in the European Organisation for Research and Treatment of Cancer 22921 trial: prognostic value and effects of preoperative radio (chemo) therapy.

Authors:  Annelies Debucquoy; Louis Libbrecht; Valerie Roobrouck; Laurence Goethals; William McBride; Karin Haustermans
Journal:  Eur J Cancer       Date:  2008-03-18       Impact factor: 9.162

6.  CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients: results from a phase II.

Authors:  V Voelter; A Zouhair; H Vuilleumier; M Matter; H Bouzourene; S Leyvraz; J Bauer; P Coucke; R Stupp
Journal:  Br J Cancer       Date:  2006-08-29       Impact factor: 7.640

Review 7.  The prognostic value of the apoptosis pathway in colorectal cancer: a review of the literature on biomarkers identified by immunohistochemistry.

Authors:  Eliane C M Zeestraten; Anne Benard; Marlies S Reimers; Philip C Schouten; Gerrit J Liefers; Cornelis J H van de Velde; Peter J K Kuppen
Journal:  Biomark Cancer       Date:  2013-07-04

8.  Subcutaneous preconditioning increases invasion and metastatic dissemination in mouse colorectal cancer models.

Authors:  Patricia Alamo; Alberto Gallardo; Miguel A Pavón; Isolda Casanova; Manuel Trias; Maria A Mangues; Esther Vázquez; Antonio Villaverde; Ramon Mangues; Maria V Céspedes
Journal:  Dis Model Mech       Date:  2014-01-30       Impact factor: 5.758

9.  Poorer outcome in stromal HIF-2 alpha- and CA9-positive colorectal adenocarcinomas is associated with wild-type TP53 but not with BNIP3 promoter hypermethylation or apoptosis.

Authors:  A H G Cleven; B G Wouters; B Schutte; A J G Spiertz; M van Engeland; A P de Bruïne
Journal:  Br J Cancer       Date:  2008-08-19       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.